BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 18223290)

  • 1. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
    Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
    Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.
    Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL
    Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.
    Trojani A; Montillo M; Nichelatti M; Tedeschi A; Colombo C; Veronese S; Mura MA; Ricci F; Scarpati B; Colosimo A; Lodola M; Morra E
    Cancer Biomark; 2010; 6(1):1-9. PubMed ID: 20164537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis.
    Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M
    Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status.
    Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J
    Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CD38 and ZAP70 mRNA expression among cytogenetic subgroups of Iranian chronic-lymphocytic-leukemia patients.
    Teimori H; Akbari MT; Hamid M; Forouzandeh M; Bibordi E
    Genet Mol Res; 2011 Oct; 10(4):2415-23. PubMed ID: 22002134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
    Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
    Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
    Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
    Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
    Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
    Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.